✦ LIBER ✦

Successful Crizotinib Rechallenge After Crizotinib-Induced Interstitial Lung Disease in Patients With Advanced Non–Small-Cell Lung Cancer

✍ Scribed by Asai, Nobuhiro; Yamaguchi, Etsuro; Kubo, Akihito

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of crizotinib in patients with

✍ Jame Abraham 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 52 KB

Budget Impact Of Crizotinib For Alk-Posi

✍ Rosado-Buzzo, A.; Garcia-Mollinedo, L.; Luna-Casas, G.; Mould-Quevedo, J.F.; Gut 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Interstitial lung disease in patients wi

✍ Kunihiko Miyazaki; Hiroaki Satoh; Koichi Kurishima; Ryota Nakamura; Hiroichi Ish 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 167 KB

Clinical Benefit From Pemetrexed Before

✍ Berge, Eamon M.; Lu, Xian; Maxson, Delee; Barón, Anna E.; Gadgeel, Shirish M.; S 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 649 KB

Overcoming the resistance to Crizotinib

✍ Perez, Cesar A.; Velez, Michel; Raez, Luis E.; Santos, Edgardo S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 868 KB

Gefitinib-Related Interstitial Lung Dise

✍ Shih-Chieh Chang; Cheng-Yu Chang; Shu-Ju Chang; Mei-Kang Yuan; Yi-Chun Lai; Yu-C 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 333 KB